CERN Cerner Corporation

Cerner and Duke Clinical Research Institute Collaborate on Cardiac Risk App

Cerner and Duke Clinical Research Institute Collaborate on Cardiac Risk App

App presents vitals and lab measurements for cardiac risk patients to facilitate dialogue and help improve health outcomes

KANSAS CITY, Mo., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, collaborated with Duke Clinical Research Institute to develop an atherosclerotic cardiovascular disease (ASCVD) Risk Calculator app, designed as a tool to increase communication between the person and their doctor about ways to live a healthier life and risk factors for heart disease and stroke.

The app helps health care providers estimate 10-year and lifetime ASCVD risk for patients based on information like age, race, sex, blood pressure, cholesterol levels, smoking status and diabetes status. If untreated, ASCVD can lead to heart attack and sudden cardiac arrest, as well as fatal and nonfatal stroke. To facilitate shared decision-making between the person and their doctor to guide treatment decisions, the app was designed to factor in a person’s willingness to take action to improve their health and the risks and benefits of potential therapies.

“Guidelines from the American College of Cardiology and American Heart Association now emphasize using the 10-year calculator to identify adults for statin therapy,” said Dr. Pierre Elias, cardiology fellow at Columbia University and former medical student at Duke University School of Medicine. “We wanted an app that would make it easier for clinicians to calculate risk at the point of care. Whether it’s the primary care clinic or a cardiologist’s office, I can’t tell you the number of times this can get missed when there are so many other problems to manage. Making it faster and easier to get news you can use leads to better patient care.”

Cerner and Duke Clinical Research Institute worked together to develop the software through the Cerner Open Developer Experience (code) that encourages innovators to build apps that advance the health care industry. Through Cerner’s open source code, doctors from Duke Clinical Research Institute provided clinical direction to create an app that could be embedded within Cerner’s electronic health record (EHR) for each patient. Cerner wrote, maintains and hosts the ASCVD Risk Calculator under an open source license.

“This collaboration demonstrates how the health care industry can come together to develop and continually improve an app that has the ability to save lives by the power of SMART on FHIR® open source standards,” said Kevin Shekleton, vice president and distinguished engineer at Cerner. “We developed this Risk Calculator for our client hospitals and health systems, but open source lets any health care organization leverage the technology to help people live healthier lives.”

“We developed the app to be able to pull important patient health data across multiple EHR suppliers at different venues of care in order to get a full picture of how to improve that patient’s health,” said Dr. Ann Marie Navar, assistant professor of Medicine (Cardiology) at Duke University School of Medicine and member of the Duke Clinical Research Institute who led the collaboration. “Cerner’s open platform encourages collaboration, which will help advance the way care is delivered regardless of the specific platform people are using.”

The ASCVD Risk Calculator app is available to providers in the and the Cerner Open Developer Experience .

About Cerner

Cerner’s health technologies connect people and information systems at more than 27,000 contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit ,  or connect on , , ,  or . Nasdaq: CERN. Smarter Care. Better Outcomes. Healthier You.

Media Contacts:

Cerner

Austin Cozzolino, Public Relations, (816) 786-2154,

EN
23/08/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cerner Corporation

CERNER sees an upgrade to Slightly Positive due to a better fundamenta...

The general evaluation of CERNER (US), a company active in the Software industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 14, 2021, the closing price was USD 77.26 and...

 PRESS RELEASE

Cerner Announces Increased Quarterly Dividend

Cerner Announces Increased Quarterly Dividend Dividend of $0.27 per issued and outstanding share reflects 23% increase KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) --  (NASDAQ: CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividend...

 PRESS RELEASE

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Offic...

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer Experienced Clinical Executive to Lead Patient and Caregiver Experiences KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality...

 PRESS RELEASE

Cerner Reports Third Quarter 2021 Results

Cerner Reports Third Quarter 2021 Results Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed as well as on the company’s website at . Cerner will host an earnings conference call to provide additional detail on the Company’s results a...

 PRESS RELEASE

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcome...

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered KANSAS CITY, Mo., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, SM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch